tiprankstipranks
Trending News
More News >
Northwest Biotherapeutics (NWBO)
:NWBO
US Market
Advertisement

Northwest Biotherapeutics (NWBO) Financial Statements

Compare
524 Followers

Northwest Biotherapeutics Financial Overview

Northwest Biotherapeutics's market cap is currently $351.91M. The company's EPS TTM is $-0.068; its P/E ratio is ―; Northwest Biotherapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Currency in USD

Northwest Biotherapeutics Earnings and Revenue History

Northwest Biotherapeutics Debt to Assets

Northwest Biotherapeutics Cash Flow

Northwest Biotherapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis